| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.27 | 8e-06 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.16 | 9e-06 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.23 | 3e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.2 | 3e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.2 | 5e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.24 | 6e-05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0006 |